Advanced Accelerators Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.
Novartis researchers are learning how a novel approach to immunotherapy could help treat cancer.
Learn about the career of our Global Medical Affairs Head for Solid Tumors and Rare Diseases.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.